Login / Signup

Comment on: The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study. Reply.

Tsai-Hung YenHsin-Hua Chen
Published in: Rheumatology (Oxford, England) (2024)
Keyphrases
  • cardiovascular events
  • systemic sclerosis
  • interstitial lung disease
  • coronary artery disease
  • cardiovascular disease
  • adverse drug
  • emergency department
  • type diabetes
  • idiopathic pulmonary fibrosis